 Treatment murine transitional cell carcinoma intralesional interleukin interferon gamma antitumor effect recombinant combination recombinant interferon gamma murine transitional cell carcinoma initial prophylactic model treatment day site tumor inoculation Maximal significant reduction tumor volume groups units recombinant interleukin colony units Bacillus Calmette Guerin vs saline control experiment reduction tumor incidence increase survival groups units recombinant interleukin units recombinant interleukin units recombinant interferon gamma colony units Bacillus Calmette Guerin relative control dose-response effect recombinant interleukin alone model transitional cell carcinoma Intralesional injection treatments tumors palpable Reduction tumor volume group units recombinant interleukin vs saline control significant advantage survival